SEC Info - Third Point LLC, et al. - ‘SC 13D/A’ on 5/24/07 re: Acorda Therapeutics Inc

SEC Info℠

Home

Help

Please Sign In

Third Point LLC, et al. – ‘SC 13D/A’ on 5/24/07 re: Acorda Therapeutics Inc

On: Thursday, 5/24/07, at 5:23pm ET · Accession #: 899140-7-1048 · File #: 5-81801

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/24/07  Third Point LLC                   SC 13D/A               1:19K  Acorda Therapeutics Inc           Willkie Fa… Gallagher/FA
          Daniel S. Loeb
          Third Point Offshore Fund, Ltd.

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment No. 1                                        9     33K

Document Table of Contents

Page	(sequential)	\|	(alphabetic)	Top
			Alternative Formats (Word, et al.) Interest in Securities of the Issuer Purpose of Transaction Schedule 13D Source and Amount of Funds or Other Consideration
1	1st Page - Filing Submission
"	Schedule 13D
5	Item 3. Source and Amount of Funds or Other Consideration
"	Item 4. Purpose of Transaction
6	Item 5. Interest in Securities of the Issuer

SC 13D/A 1st Page of 9 TOC ↑Top Previous Next ↓Bottom Just 1st
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
 (Amendment No. 1)

Under the Securities Exchange Act of 1934*

 Acorda Therapeutics, Inc.
------------------------------------------------------------- 
(Name of Issuer)

Common Stock, par value $0.001 per share
------------------------------------------------------------- 
(Title of Class of Securities)

 00484M106
------------------------------------------------------------- 
 (CUSIP Number of Class of Securities)

Daniel S. Loeb
 Third Point LLC
 390 Park Avenue
New York, NY 10022
(212) 224-7400
------------------------------------------------------------- 
 (Name, Address and Telephone Number of Person
 Authorized to Receive Notices and Communications)

Copies to:
 Michael A. Schwartz, Esq.
Willkie Farr & Gallagher LLP
787 Seventh Avenue
 New York, NY 10019-6099
(212) 728-8000

May 22, 2007
------------------------------------------------------------- 
 (Date of Event which Requires
Filing of this Schedule)

If the filing person has previously filed a statement on Schedule 13G to report 
the acquisition which is the subject of this Schedule 13D, and is filing this   
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box: [ ]                                                              

NOTE: Schedules filed in paper format shall include a signed original and five  
copies of the schedule, including all exhibits. See Rule 240.13d-7 for other    
parties to whom copies are to be sent.                                          

* The remainder of this cover page shall be filled out for a reporting person's 
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter           
disclosures provided in a prior cover page.                                     

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of   
1934 ("Act") or otherwise subject to the liabilities of that section of the Act 
but shall be subject to all other provisions of the Act (however, see the       
Notes).                                                                         

SC 13D/A 2nd Page of 9 TOC 1st Previous Next ↓Bottom Just 2nd
SCHEDULE 13D

----------------------------                              ----------------------
CUSIP No. 00484M106                                       Page 2 of 9 Pages     
----------------------------                              ----------------------

----------- --------------------------------------------------------------------
1       NAME OF REPORTING PERSON                                        
   I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Third Point LLC                                         
----------- --------------------------------------------------------------------
 2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP          (a) [ ]
                                                                   (b) [X]

----------- --------------------------------------------------------------------
3       SEC USE ONLY                                                    

----------- --------------------------------------------------------------------
4       SOURCE OF FUNDS*                                                

AF                                                      
----------- --------------------------------------------------------------------
5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED         
         PURSUANT TO ITEMS 2(d) or 2(e)                                [ ]

----------- --------------------------------------------------------------------
6       CITIZENSHIP OR PLACE OF ORGANIZATION                            

Delaware                                                
--------------------- --------- ------------------------------------------------
7      SOLE VOTING POWER      

0               
                      --------- ------------------------------------------------
NUMBER OF                8      SHARED VOTING POWER                             
SHARES                                                                          
BENEFICIALLY                    1,000,000                                       
OWNED BY              --------- ------------------------------------------------
EACH                     9      SOLE DISPOSITIVE POWER                          
REPORTING                                                                       
PERSON WITH                     0                                               
                      --------- ------------------------------------------------
 10     SHARED DISPOSITIVE POWER

1,000,000       
----------- --------------------------------------------------------------------
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON              

1,000,000                                               
----------- --------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES          
         CERTAIN SHARES*                                               [ ]

----------- --------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)              

4.1%                                                    
----------- --------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*                                       

OO                                                      
----------- --------------------------------------------------------------------

SC 13D/A 3rd Page of 9 TOC 1st Previous Next ↓Bottom Just 3rd
SCHEDULE 13D

----------------------------                              ----------------------
CUSIP No. 00484M106                                       Page 3 of 9 Pages     
----------------------------                              ----------------------

----------- --------------------------------------------------------------------
1       NAME OF REPORTING PERSON                                        
   I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Daniel S. Loeb                                          
----------- --------------------------------------------------------------------
 2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP          (a) [ ]
                                                                   (b) [X]

----------- --------------------------------------------------------------------
3       SEC USE ONLY                                                    

----------- --------------------------------------------------------------------
4       SOURCE OF FUNDS*                                                

AF                                                      
----------- --------------------------------------------------------------------
5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED         
         PURSUANT TO ITEMS 2(d) or 2(e)                                [ ]

----------- --------------------------------------------------------------------
6       CITIZENSHIP OR PLACE OF ORGANIZATION                            

United States                                           
--------------------- --------- ------------------------------------------------
7      SOLE VOTING POWER      

0               
                      --------- ------------------------------------------------
NUMBER OF                8      SHARED VOTING POWER                             
SHARES                                                                          
BENEFICIALLY                    1,000,000                                       
OWNED BY              --------- ------------------------------------------------
EACH                     9      SOLE DISPOSITIVE POWER                          
REPORTING                                                                       
PERSON WITH                     0                                               
                      --------- ------------------------------------------------
 10     SHARED DISPOSITIVE POWER

1,000,000       
----------- --------------------------------------------------------------------
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON              

1,000,000                                               
----------- --------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES          
         CERTAIN SHARES*                                               [ ]

----------- --------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)              

4.1%                                                    
----------- --------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*                                       

IN                                                      
----------- --------------------------------------------------------------------

SC 13D/A 4th Page of 9 TOC 1st Previous Next ↓Bottom Just 4th
SCHEDULE 13D

----------------------------                              ----------------------
CUSIP No. 00484M106                                       Page 4 of 9 Pages     
----------------------------                              ----------------------

----------- --------------------------------------------------------------------
1       NAME OF REPORTING PERSON                                        
   I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Third Point Offshore Fund, Ltd.                         
----------- --------------------------------------------------------------------
 2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP          (a) [ ]
                                                                   (b) [X]

----------- --------------------------------------------------------------------
3       SEC USE ONLY                                                    

----------- --------------------------------------------------------------------
4       SOURCE OF FUNDS*                                                

AF                                                      
----------- --------------------------------------------------------------------
5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED         
         PURSUANT TO ITEMS 2(d) or 2(e)                                [ ]

----------- --------------------------------------------------------------------
6       CITIZENSHIP OR PLACE OF ORGANIZATION                            

Cayman Islands                                          
--------------------- --------- ------------------------------------------------
7      SOLE VOTING POWER      

0               
                      --------- ------------------------------------------------
NUMBER OF                8      SHARED VOTING POWER                             
SHARES                                                                          
BENEFICIALLY                    661,400                                         
OWNED BY              --------- ------------------------------------------------
EACH                     9      SOLE DISPOSITIVE POWER                          
REPORTING                                                                       
PERSON WITH                     0                                               
                      --------- ------------------------------------------------
 10     SHARED DISPOSITIVE POWER

661,400         
----------- --------------------------------------------------------------------
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON              

661,400                                                 
----------- --------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES          
         CERTAIN SHARES*                                               [ ]

----------- --------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)              

2.7%                                                    
----------- --------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*                                       

OO                                                      
----------- --------------------------------------------------------------------

SC 13D/A 5th Page of 9 TOC 1st Previous Next ↓Bottom Just 5th
  This Amendment No. 1 to Schedule 13D (this "Amendment No. 1") amends the
Schedule 13D filed on February 22, 2007 (as amended by this Amendment No. 1, the
"Schedule 13D") and is being filed on behalf of Third Point LLC, a Delaware     
limited liability company (the "Management Company"), Third Point Offshore Fund,
Ltd., a Cayman Islands limited liability exempted company (the "Offshore Fund"),
Daniel S. Loeb, an individual ("Mr. Loeb", and together with the Management     
Company and the Offshore Fund, the "Reporting Persons"). This Amendment No. 1   
relates to the Common Stock, par value $0.001 per share, of Acorda Therapeutics,
Inc., a Delaware corporation (the "Company"). Unless the context otherwise      
requires, references herein to the "Common Stock" are to such Common Stock of   
the Company. The Management Company is the investment manager or adviser to a   
variety of hedge funds and managed accounts (such funds and accounts,           
collectively, including but not limited to Offshore Fund, the "Funds"). The     
Funds directly own the Common Stock to which this Schedule 13D relates, and the 
Management Company and Mr. Loeb may be deemed to have beneficial ownership over 
such Common Stock by virtue of the authority granted to them by the Funds to    
vote and to dispose of the securities held by the Funds, including the Common   
Stock.                                                                          

Item 3.   Source and Amount of Funds or Other                                   
Consideration.                                              

Item 3 of the Schedule 13D is hereby amended and restated as follows: 

   The Funds expended an aggregate of approximately $12,281,278 of their own
investment capital to acquire the 1,000,000 shares of Common Stock held by them.
Offshore Fund expended an aggregate of approximately $7,966,978 of its own      
investment capital to acquire its 661,400 shares of Common Stock. The Funds     
effect purchases of securities primarily through margin accounts maintained for 
them with Bear, Stearns Securities Corp. and Goldman, Sachs & Co., which may    
extend margin credit to the Funds as and when required to open or carry         
positions in the margin accounts, subject to applicable Federal margin          
regulations, stock exchange rules and the firm's credit policies. In such       
instances, the positions held in the margin accounts are pledged as collateral  
security for the repayment of debit balances in the accounts.                   

Item 4.   Purpose of Transaction.                                               

     The Reporting Persons have reduced their beneficial ownership of the Common
Stock, while still maintaining substantial beneficial ownership, in order to    
reallocate capital to other investment opportunities within the biotechnology   
industry.                                                                       

5 

SC 13D/A 6th Page of 9 TOC 1st Previous Next ↓Bottom Just 6th
Item 5.   Interest in Securities of the Issuer.                                 

Item 5 of the Schedule 13D is hereby amended and restated as follows: 

(a) As of the date of this Schedule 13D, the Management Company       
beneficially owns 1,000,000 shares of Common Stock (the "Shares"). The Shares   
represent 4.1% of the 24,126,972 shares of Common Stock outstanding as of April 
30, 2007, as reported in the Company's Quarterly Report on Form 10-Q for the    
quarterly period ended March 31, 2007. The percentages used herein and in the   
rest of this statement are calculated based upon this number of outstanding     
shares.                                                                         

As of the date of this Schedule 13D, the Offshore Fund directly       
beneficially owns 661,400 shares of Common Stock, which represent 2.7% of the   
outstanding shares of Common Stock. None of the other individual Funds owns a   
number of shares of Common Stock representing more than 5% of such total.       

    (b) The Management Company and Mr. Loeb share voting and dispositive power
over the 1,000,000 shares of Common Stock held directly by the Funds. The       
Management Company, Mr. Loeb and Offshore Fund share voting power and           
dispositive power over the 661,400 shares of Common Stock held by Offshore Fund.

(c) Schedule A hereto sets forth certain information with respect to  
transactions by the Funds, at the direction of the Reporting Persons, in the    
Common Stock during the past 60 days. Schedule B hereto sets forth certain      
information with respect to transactions by the Offshore Fund, at the direction 
of the Management Company and Mr. Loeb, in the Common Stock during the past 60  
days.                                                                           

All of the transactions set forth on Schedule A and Schedule B were   
effected in the NASDAQ Global Market. Except as set forth on Schedule A and     
Schedule B, during the last 60 days there were no transactions in the Common    
Stock effected by the Reporting Persons, nor, to the best of their knowledge,   
any of their directors, executive officers, general partners or members.        

    (d) Other than the Funds which directly hold the Shares, and except as set
forth in this Item 5, no person is known to have the right to receive or the    
power to direct the receipt of dividends from, or the proceeds from the sale of,
the Shares.                                                                     

     (e) Each of the Reporting Persons ceased to be the beneficial owner of more
than five percent of the total outstanding Common Stock on May 22, 2007.        

[Signatures on following page]

6 

SC 13D/A 7th Page of 9 TOC 1st Previous Next ↓Bottom Just 7th
SIGNATURES

   After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,   
complete and correct.                                                           

Dated: May 24, 2007                                                             

 THIRD POINT LLC

     By: Daniel S. Loeb,
                 Chief Executive Officer

         By:   /s/ Justin Nadler
                                       -----------------------------------------
                  Name:  Justin Nadler
                     Title: Attorney-in-Fact

                 THIRD POINT OFFSHORE FUND, LTD.

     By: Daniel S. Loeb,
  Director

       By:   /s/ Justin Nadler
                                       -----------------------------------------
                  Name:  Justin Nadler
                     Title: Attorney-in-Fact

DANIEL S. LOEB

         By:   /s/ Justin Nadler
                                       -----------------------------------------
                  Name:  Justin Nadler
                     Title: Attorney-in-Fact

[SIGNATURE PAGE TO AMENDMENT NO. 1 TO SCHEDULE 13D
WITH RESPECT TO ACORDA THERAPEUTICS, INC.]

SC 13D/A 8th Page of 9 TOC 1st Previous Next ↓Bottom Just 8th
Schedule A

(Transactions by the Funds in Common Stock
during the past 60 days)

   Date           Transaction           Shares          Price Per Share($)
   ----           -----------           ------          ------------------

---------------- ------------------- ------------------ ------------------------
03/30/07             SELL             (9,700)                19.42      
---------------- ------------------- ------------------ ------------------------
03/30/07             BUY               9,700                 19.42      
---------------- ------------------- ------------------ ------------------------
04/30/07             SELL             (16,400)               24.78      
---------------- ------------------- ------------------ ------------------------
04/30/07             BUY               16,400                24.78      
---------------- ------------------- ------------------ ------------------------
05/09/07             SELL             (35,000)               25.16      
---------------- ------------------- ------------------ ------------------------
05/09/07             SELL             (5,000)                25.09      
---------------- ------------------- ------------------ ------------------------
05/10/07             SELL             (5,000)                25.03      
---------------- ------------------- ------------------ ------------------------
05/10/07             SELL             (7,000)                25.00      
---------------- ------------------- ------------------ ------------------------
05/11/07             SELL             (23,000)               23.88      
---------------- ------------------- ------------------ ------------------------
05/15/07             SELL             (35,000)               22.48      
---------------- ------------------- ------------------ ------------------------
05/16/07             SELL             (30,000)               22.28      
---------------- ------------------- ------------------ ------------------------
05/22/07             SELL           (1,000,000)              24.25      
---------------- ------------------- ------------------ ------------------------
05/23/07             SELL            (150,000)               24.25      
---------------- ------------------- ------------------ ------------------------

SC 13D/A Last Page of 9 TOC 1st Previous Next ↓Bottom Just 9th
Schedule B

(Transactions by the Offshore Fund in Common Stock
during the past 60 days)

   Date           Transaction           Shares          Price Per Share($)

---------------- ------------------- ------------------ ------------------------
03/30/07             BUY               1,000                 19.42      
---------------- ------------------- ------------------ ------------------------
04/30/07             SELL             (5,700)                24.78      
---------------- ------------------- ------------------ ------------------------
05/09/07             SELL             (25,600)               25.16      
---------------- ------------------- ------------------ ------------------------
05/09/07             SELL             (3,700)                25.09      
---------------- ------------------- ------------------ ------------------------
05/10/07             SELL             (1,000)                25.00      
---------------- ------------------- ------------------ ------------------------
05/11/07             SELL             (14,800)               23.88      
---------------- ------------------- ------------------ ------------------------
05/15/07             SELL             (27,100)               22.48      
---------------- ------------------- ------------------ ------------------------
05/16/07             SELL             (20,800)               22.28      
---------------- ------------------- ------------------ ------------------------
05/22/07             SELL            (643,000)               24.25      
---------------- ------------------- ------------------ ------------------------
05/23/07             SELL             (96,300)               24.25      
---------------- ------------------- ------------------ ------------------------

SC 13D/A	1st Page of 9	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

SC 13D/A	2nd Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 2nd

SC 13D/A	3rd Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 3rd

SC 13D/A	4th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 4th

SC 13D/A	5th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 5th

SC 13D/A	6th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 6th

SC 13D/A	7th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 7th

SC 13D/A	8th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 8th

SC 13D/A	Last Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 9th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘SC 13D/A’ Filing	Date	First	Last	Other Filings

Filed on:	5/24/07	7		4
	5/22/07	1	6	8-K, SC 13D/A
	4/30/07	6
	3/31/07	6		10-Q, 13F-HR
	2/22/07	5		4, SC 13D
				List all Filings

↑Top

Filing Submission 0000899140-07-001048 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Third Point LLC, et al. – ‘SC 13D/A’ on 5/24/07 re: Acorda Therapeutics Inc

On: Thursday, 5/24/07, at 5:23pm ET · Accession #: 899140-7-1048 · File #: 5-81801

Previous ‘SC 13D’: ‘SC 13D/A’ on 5/22/07 · Next: ‘SC 13D/A’ on 5/31/07 · Latest: ‘SC 13D’ on 2/13/24

Amendment to General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

Document Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents